Large-scale resolution of lawsuits related to the popular birth control drugs Yaz and Yasmin continues to progress, with the achievement of settlements in hundreds of blood clot cases and the recent revelation that similar outcomes are likely in several hundred additional matters pending in the... Read More

In a complete reversal of their recent position, Bayer Healthcare has decided to pay $56.9 million in a Yaz injury settlement to 1,200 individuals who have been seeking damages in federal court for arterial thromboembolism (ATE) injuries caused by ingesting the birth control drugs Yaz... Read More

A December 5 trial selection order issued by U.S. District Judge David R. Herndon has identified 33 Yasmin and Yaz birth control lawsuits to be readied for trials that may begin as soon as May of 2015. The cases included in Judge Herndon's order all... Read More

Judge David Herndon of the U.S. District Court for the Southern District of Illinois has set a May 2015 trial date for a number of Yaz and Yasmin lawsuits in which settlements have not yet been reached between plaintiffs and Bayer HealthCare. While Bayer has... Read More

A recent decision by the Alabama Supreme Court may have far-reaching effects on litigation arising from prescription pharmaceuticals and their generic counterparts. In a 6-3 decision, the panel determined that manufacturers of the acid reflux drug Reglan could be held liable for failing to warn... Read More

Although Bayer has already paid more than $1.8 billion to settle Yasmin and Yaz lawsuits, the company reports that approximately 5,000 lawsuits are still pending in the court system. The company’s 2014 second-quarter financial report notes that Bayer has reached settlement agreements with more than... Read More

A 43-year-old Chicago woman received vindication in April when a jury awarded her $14 million in damages after she suffered a stroke six years earlier, at the age of 37, within two weeks of taking the birth control pill Yasmin. (or “Yaz”). The Yasmin birth... Read More

Bayer has indicated it intends to provide thousands of Yaz settlements to plaintiffs with cases currently pending in the United States. According to the company’s 2013 Annual Report, Bayer plans to spend approximately $1.69 billion to settle lawsuits alleging blood clots and other venous disorders,... Read More